(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Iran warns its ready to open new front in Yemen, close Bab al-Mandab Strait with Houthis - 2Gulf countries roll out more autonomous taxis
- 3RSF attack on Sudan’s South Kordofan kills at least 14, including children
- 4Step by step instructions to Pick the Ideal Authorize Internet Advertising Degree Program
- 5Former 'Bachelorette' welcomes 1st baby via emergency c-section
- CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth
- 4 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- Vote In favor of Your Favored Keeping an eye on
- Ice Spice's 'Big Guy' SpongeBob song is stuck in everyone's heads again — and TikTok is fueling it
- Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- Foreign military officials can become Israel's ambassadors, senior IDF commander tells 'Post'
- Wizz CEO: We’re going to invest $1 b. in Israeli market
- US students studying housing, health outcomes and sustainability win 2026 Rhodes scholarships
- Select Your Cherished Fish
